Microscopic illustration of corneal flap adhesion with tissue glue.

LASIK Complications: How a 'Tissue Glue' Could Revolutionize Corneal Flap Procedures

Author's portrait.
Rhea Morgan in Health & Wellness December 2025 • 4 min read.

"Researchers explore the molecular mechanisms behind a fibrinogen, riboflavin, and UVA light treatment to improve corneal flap adhesion and reduce post-LASIK issues."


LASIK (laser-assisted in situ keratomileusis) surgery, while highly effective in correcting vision, isn't without potential complications. Issues such as corneal wound instability and epithelial ingrowth can lead to significant post-operative discomfort and visual disturbances. Now, imagine a future where these risks are minimized, thanks to a revolutionary 'tissue glue'.

Researchers have been investigating a unique combination of fibrinogen (FIB), riboflavin (RF), and ultraviolet A (UVA) light to create a strong, biocompatible adhesive for corneal flaps. Previous studies have shown that this mixture can effectively adhere two stromal surfaces, but the precise molecular mechanisms behind this adhesion have remained unclear – until now.

A new study delves into the specific interactions between corneal extracellular matrix (ECM) and tissue glue molecules, documenting both covalent and noncovalent bonds that contribute to the adhesion created by FIB, RF, and UVA. This breakthrough could pave the way for safer, more predictable LASIK outcomes and potentially other corneal surgeries.

Decoding the 'Tissue Glue': How Fibrinogen, Riboflavin, and UVA Create a Stronger Bond

Microscopic illustration of corneal flap adhesion with tissue glue.

The research team employed sophisticated techniques like SDS-PAGE, Western blotting, and surface plasmon resonance (SPR) to dissect the molecular interactions at play. These methods allowed them to identify both covalent bonds (strong, permanent links) and noncovalent interactions (weaker, reversible attractions) between the tissue glue and the cornea.

The results revealed that when fibrinogen, riboflavin, and UVA light are combined, neighboring fibrinogen molecules form covalent bonds with each other. Even more importantly, fibrinogen also forms covalent links with collagen type I (Coll-I), a major structural protein in the corneal stroma. These interactions, however, only occurred in the presence of both riboflavin and UVA light, highlighting the crucial role of photoactivation in the adhesion process.

Here's a breakdown of the key components and their roles:
  • Fibrinogen (FIB): The main component of the tissue glue, acting as the primary adhesive molecule.
  • Riboflavin (RF): A photosensitizer that, when activated by UVA light, catalyzes the formation of covalent bonds.
  • Ultraviolet A (UVA) Light: Activates riboflavin, initiating the crosslinking reactions that strengthen the adhesion.
  • Collagen Type I (Coll-I): The most abundant protein in the corneal stroma, providing a structural framework for adhesion.
Beyond covalent bonds, the study also uncovered crucial noncovalent interactions. Using SPR, the researchers demonstrated that fibrinogen can bind to various corneal stroma molecules, including Coll-I, decorin, dermatan sulfate, laminin, and heparan sulfate. Interestingly, this binding was dependent on the presence of zinc ions (Zn2+), suggesting that zinc acts as a bridge, facilitating the interaction between fibrinogen and these ECM components.

A Glimmer of Hope for Better LASIK Outcomes

This research provides valuable insights into the complex molecular mechanisms that underpin the adhesion created by fibrinogen, riboflavin, and UVA light. By understanding how these molecules interact with the corneal tissue, scientists can optimize the tissue glue for even greater strength, biocompatibility, and predictability.

The combination of covalent and noncovalent mechanisms offers a multi-pronged approach to corneal flap stabilization. Covalent bonds provide robust, long-lasting adhesion, while zinc-mediated noncovalent interactions contribute to the initial attachment and integration of the flap with the surrounding tissue.

While further research is needed, this innovative approach holds significant promise for reducing complications associated with LASIK and other corneal surgeries, ultimately leading to improved outcomes and enhanced patient satisfaction. The future of corneal procedures may very well be glued together, one molecule at a time.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1167/iovs.12-10201, Alternate LINK

Title: Fibrinogen, Riboflavin, And Uva To Immobilize A Corneal Flap – Molecular Mechanisms

Subject: General Medicine

Journal: Investigative Opthalmology & Visual Science

Publisher: Association for Research in Vision and Ophthalmology (ARVO)

Authors: Stacy L. Littlechild, Yuntao Zhang, John M. Tomich, Gary W. Conrad

Published: 2012-09-06

Everything You Need To Know

1

What exactly is this 'tissue glue' made of, and how does each component contribute to corneal adhesion?

The tissue glue uses a combination of fibrinogen (FIB), riboflavin (RF), and ultraviolet A (UVA) light. Fibrinogen acts as the main adhesive. Riboflavin, when activated by UVA light, helps form covalent bonds. UVA light activates riboflavin, starting the crosslinking that strengthens adhesion. These components work together to create a strong, biocompatible adhesive for corneal flaps.

2

What molecular interactions were discovered, and how do covalent and noncovalent bonds play a role?

The study revealed that fibrinogen forms covalent bonds with itself and, importantly, with collagen type I (Coll-I), a key structural protein in the corneal stroma. These covalent links are essential for strong adhesion and only occur when riboflavin is activated by UVA light. The study also found noncovalent interactions between fibrinogen and various corneal stroma molecules, facilitated by zinc ions (Zn2+).

3

Why is collagen type I (Coll-I) so important in this tissue glue application?

Collagen type I (Coll-I) is vital because it's the most abundant protein in the corneal stroma, providing a structural framework for adhesion. Fibrinogen forms covalent bonds with collagen type I in the presence of riboflavin and UVA light. This interaction significantly strengthens the bond between the corneal flap and the underlying tissue, enhancing the overall stability of the LASIK procedure.

4

What aspects of the tissue glue's effects are still unknown or require further research?

While the research highlights the importance of fibrinogen, riboflavin, UVA light, collagen type I, and zinc ions in corneal flap adhesion, it does not delve into the long-term effects of these interactions on corneal health. Future studies could explore the longevity of the bonds created by the tissue glue and the potential for degradation or adverse reactions over time. Additionally, the optimal concentrations of fibrinogen and riboflavin, as well as the ideal UVA light exposure parameters, could be further investigated to maximize the effectiveness and safety of the tissue glue.

5

What are the broader implications of this research for improving LASIK surgery and other corneal procedures?

By understanding how fibrinogen, riboflavin, and UVA light interact with corneal tissue, scientists can refine the tissue glue for increased strength, biocompatibility, and predictability. This could lead to safer LASIK outcomes with fewer complications like epithelial ingrowth and corneal wound instability. Further research could also explore the potential of this tissue glue in other corneal surgeries, expanding its applications beyond LASIK.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.